September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
TORe Procedure Blazes New Path for Gastric Bypass Patients Part 4
While TORe has been a significant development in the treatment of overweight and obese patients who have undergone gastric bypass surgery there are more procedures on the horizon that could provide even greater benefits in the future.
TORe Procedure Blazes New Path for Gastric Bypass Patients Part 3
Even more so than gastric bypass surgery, the work of the patient determines how effective TORe can be in helping them keep from re-gaining excess weight. With diet, exercise, and working with their healthcare professionals the results can be positive for everyone involved.
TORe Procedure Blazes New Path for Gastric Bypass Patients Part 2
While gastric bypass has provided benefits for millions of patients it has not been without its share of complications and difficulties after the procedure. Over the past few years work has been done to find ways to help patients after undergoing the original operation.
TORe Procedure Blazes New Path for Gastric Bypass Patients
Across the country millions of people have undergone gastric bypass surgery in an effort to lose weight and improve their overall health. For those patients who have seen their results diminish a relatively new procedure could get them back on the road to a healthy lifestyle.
Newly Diagnosed Diabetes Cases Rise after Medicaid Expansion Spurs Patient Testing
In states that expanded the number of low-income people eligible for Medicaid under the Affordable Care Act, the number of people with newly diagnosed type 2 diabetes increased by 23 percent.
BMI and the Risk of All-Cause Mortality Among Patients with Type 2 Diabetes Mellitus
March 30th 2015Studies have identified lower-than-normal BMIs to be associated with higher mortality in comparison with normal body weight and overweight individuals in patients with coronary artery disease. This has given rise to the term "obesity paradox" in which being overweight/obese confers a survival advantage in individuals that have been diagnosed with a medical condition. Against this backdrop, this study attempted to evaluate whether there is an association between BMI and death risk among patients with type 2 diabetes mellitus.
African Team Researches Onion Extract for Glucose Control
Doctors around the world face their own individual challenges depending on where they are working with patients. In Africa those challenges include not only difficulty affording medication, but in some cases having proper ways to properly store them.
Managing Comorbid Type 2 Diabetes Mellitus and HIV
March 24th 2015Approximately 14% of patients infected with human immunodeficiency virus (HIV) also have type 2 diabetes mellitus. That number is expected to rise as the population of HIV-infected patients ages and develop associated chronic comorbidities.
Comprehensive Health Model Provides Prediabetes Reversal
A recent Centers for Disease Control and Prevention (CDC) study revealed 86 million Americans suffer from prediabetes, a modifiable risk factor for cardiovascular disease (CVD), and nearly half of prediabetic patients were reported to develop frank diabetes.